From: How to design a national genomic project—a systematic review of active projects
Country | Planned number of WES and/or genome analyses | Country | % of the population to be sequenced |
---|---|---|---|
China | 100,000,000 | Estonia | 32.4572 |
USA | +1,000,000 | Ireland | 8.1276 |
Estonia | 430,000 | China | 7.1374 |
Ireland | 400,000 | Qatar | 3.6400 |
Japan | 250,000 | Malta | 0.8510 |
France | 235,000 | France | 0.3503 |
Canada | 130,000 | Canada | 0.3430 |
Qatar | 100,000 | Saudi Arabia | 0.3098 |
Saudi Arabia | 100,000 | USA | 0.3037 |
Turkey | 100,000 | Hong Kong | 0.2658 |
UK | 100,000 | Japan | 0.1984 |
Australia | 25,000 | Latvia | 0.1974 |
Hong Kong | 20,000 | Finland | 0.1809 |
Brazil | 15,000 | Singapore | 0.1753 |
Finland | 10,000 | UK | 0.1505 |
Taiwan | 10,000 | Turkey | 0.1219 |
Thailand | 10,000 | Cyprus | 0.1142 |
South Korea | 10,000 | Australia | 0.0977 |
Singapore | 10,000 | Taiwan | 0.0424 |
Mexico | 10,000 | Denmark | 0.0283 |
Poland | 5000 | South Korea | 0.0193 |
Malta | 4200 | Chile | 0.0157 |
Latvia | 3769 | Thailand | 0.0150 |
Russia | 3000 | Slovenia | 0.0144 |
Chile | 3000 | Poland | 0.0130 |
Denmark | 1650 | New Zealand | 0.0121 |
Czech Republic | 1055 | United Arab Emirates | 0.0102 |
Cyprus | 1000 | Czech Republic | 0.0099 |
United Arab Emirates | 1000 | Mexico | 0.0079 |
Vietnam | 1000 | Brazil | 0.0072 |
Iran | 800 | Netherlands | 0.0044 |
Netherlands | 750 | Uruguay | 0.0023 |
New Zealand | 600 | Russia | 0.0020 |
Slovenia | 300 | Vietnam | 0.0010 |
Egypt | 110 | Iran | 0.0010 |
Bangladesh | 100 | Egypt | 0.0001 |
Uruguay | 80 | Bangladesh | 0.0001 |